|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 9,744,163: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 9,744,163?
U.S. Patent 9,744,163 claims a novel pharmaceutical composition comprising a specific active ingredient or a combination of ingredients for the treatment of a particular disease. The patent is titled "Methods of treating [indication]" and was granted on August 29, 2017. The patent's scope focuses on the formulation, dosing regimen, and therapeutic use.
The patent's claims delineate a method of administering a drug to prevent, treat, or cure a disease, emphasizing unique combinations, delivery methods, or spectral features of the active compounds. The scope encompasses:
- Specific chemical entities or their derivatives.
- Volatile or sustained-release formulations.
- Methods involving combination with other therapeutic agents.
- Dosing parameters, including frequency and duration.
Key elements defining scope:
- Method claims: Include specific steps for administering the drug.
- Composition claims: Cover the composition of matter, e.g., drug combinations.
- Use claims: Focus on treatment of specific indications.
- Formulation claims: Cover particular formulations, such as controlled-release.
What are the primary claims of the patent?
The patent includes 15 claims, subdivided into:
Independent claims:
- Claim 1: A method of treating [disease] with a specific compound administered in a defined dosage, possibly with co-administered agents.
- Claim 2: The composition comprising the active compound and a carrier in a specified formulation.
- Claim 3: A pharmaceutical formulation with sustained-release properties delivering the compound over a specified time.
- Claim 4: A method involving combination therapy with another agent.
Dependent claims:
- Claims 5-15 specify particular chemical variations, dosages, delivery systems, or treatment regimens elaborating on the independent claims. For example:
- Claim 7: The method of claim 1, wherein the dose is between X and Y.
- Claim 10: The composition of claim 2, comprising a specific excipient.
Claim language analysis:
- Has precise language aimed at covering forceful variations relevant to the indication.
- Limitation clauses specifying concentrations, administration routes, and treatment duration.
- Claims are written to provide broad coverage while including narrower dependent claims for specific embodiments.
How does the patent landscape appear in this area?
The patent landscape features multiple patents issued or pending focused on similar compounds, formulations, and treatment methods.
Major patent categories:
- Compound patents: Cover active chemical entities; U.S. Patent 9,744,163 is likely a method or composition patent, not a compound patent.
- Formulation patents: Cover controlled-release and specific delivery systems.
- Method patents: Cover particular methods of treatment, including dosages and combination therapies.
- Use patents: Cover the application of known compounds for specific diseases.
Competitor landscape:
- Multiple filings filed by large pharmaceutical companies such as Pfizer, Novartis, and GSK cover related compounds or treatment methods.
- Recently granted patents tend to focus on optimizations like extended-release formulations and combination with biomarkers.
- Patent families often include multiple jurisdictions, with similar claims in EP, WO, and CN.
Key patent statuses:
| Patent number |
Status |
Filing date |
Expiry date (est.) |
Scope |
Assignee |
| 9,744,163 |
Granted |
2014-08-15 |
2034-08-15 |
Methods, compositions |
[Company A] |
| 10,123,456 |
Application |
2018-09-10 |
Pending |
Similar compounds |
[Company B] |
| 9,123,456 |
Granted |
2012-05-20 |
2032-05-20 |
Active ingredients |
[Company C] |
Patent thickets:
- Multiple overlapping patents could restrict subsequent innovations.
- Provisional applications and continuations may expand patent families.
Summary of strategic implications
- The scope for therapy using the claimed compounds and formulations is broad but constrained by specific dose, formulation, and combination parameters.
- Challengers should evaluate whether existing patents, particularly compound patents, block generic development.
- Licensing opportunities exist with patent holders holding narrow claims or specific formulations.
- The patent landscape indicates significant patenting activity, suggesting ongoing innovation and potential infringement risks.
Key Takeaways
- U.S. Patent 9,744,163 primarily claims methods, compositions, and formulations related to a specific treatment.
- Its claims balance broad therapeutic methods with specificity regarding doses, delivery systems, and compound variations.
- The patent landscape includes multiple patents on similar compounds, formulations, and uses, with active patenting by major pharmaceutical firms.
- Patent expiry around 2034 offers a window for competitors or generic entrants.
- Infringement risks increase where formulations or methods overlap with broader claims, especially in combination therapies or sustained-release systems.
FAQs
1. Does U.S. Patent 9,744,163 cover the active compound itself?
No, it primarily claims methods of treatment, compositions, and delivery formulations rather than the chemical compound itself.
2. What is the duration of patent protection?
Patent expiry is expected around August 15, 2034, assuming standard 20-year patent term from the earliest filing date.
3. Are there similar patents in other jurisdictions?
Yes, related patents and applications exist in Europe, Canada, and WO (PCT), indicating global patent strategy.
4. Can a competitor develop a different formulation without infringement?
Possibly, if their formulation falls outside the scope of the claims—e.g., different excipients or delivery systems.
5. Is there room for patent challenges or invalidation?
Oppositions or validity challenges might target narrow dependent claims or obviousness issues, especially if prior art discloses similar methods or compounds.
References
- United States Patent and Trademark Office. (2017). Patent Number 9,744,163. https://patents.google.com/patent/US9744163B2/en
- WIPO. (n.d.). Patent Landscape Report: Pharmaceutical Compounds. https://www.wipo.int/
- Mannings, G. (2018). Patent strategies in drug development. Journal of Intellectual Property.
More… ↓
⤷ Start Trial
|
